Natural history of bleeding and characteristics of early bleeders among warfarin initiators – a cohort study in Finland

References

• KirleyKQatoDMKornfieldRNational trends in oral anticoagulant use in the United States, 2007 to 2011Circ Cardiovasc Qual Outcomes20125561562122949490
   PubMed Web of Science ®Google Scholar
• LindhJDHolmLDahlMLIncidence and predictors of severe bleeding during warfarin treatmentJ Thromb Thrombolysis200825215115917514429
   PubMed Web of Science ®Google Scholar
• VirjoIMäkeläKAhoJWho receives anticoagulant treatment with warfarin and why? A population-based study in FinlandScand J Prim Health Care201028423724120822374
   PubMed Web of Science ®Google Scholar
• WielochMSjälanderAFrykmanVAnticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculAEur Heart J201132182282228921616951
   PubMed Web of Science ®Google Scholar
• GoASHylekEMChangYAnticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?JAMA2003290202685269214645310
   PubMed Web of Science ®Google Scholar
• HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med20071461285786717577005
   PubMed Web of Science ®Google Scholar
• BoulangerLHauchOFriedmanMWarfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillationAnn Pharmacother20064061024102916735649
   PubMed Web of Science ®Google Scholar
• DarkowTVanderplasAMLewKHTreatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care systemCurr Med Res Opin200521101583159416238898
   PubMed Web of Science ®Google Scholar
• FribergLRosenqvistMLipGYNet clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort studyCirculation2012125192298230722514252
   PubMed Web of Science ®Google Scholar
• GallagherAMvan StaaTPMurray-ThomasTPopulation-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomesBMJ Open201441e003839
   PubMed Web of Science ®Google Scholar
• GomesTMamdaniMMHolbrookAMRates of hemorrhage during warfarin therapy for atrial fibrillationCMAJ20131852E121E12723184840
   PubMed Web of Science ®Google Scholar
• HansenMLSørensenRClausenMTRisk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillationArch Intern Med2010170161433144120837828
   PubMed Web of Science ®Google Scholar
• LarsenTBGorst-RasmussenARasmussenLHBleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillationAm J Med2014127765065624530792
   PubMed Web of Science ®Google Scholar
• MercaldiCJCiarametaroMHahnBCost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillationStroke201142111211821148442
   PubMed Web of Science ®Google Scholar
• OlesenJBLipGYHansenPRBleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohortJ Thromb Haemost2011981460146721624047
   PubMed Web of Science ®Google Scholar
• SørensenRGislasonGTorp-PedersenCDabigatran use in Danish atrial fibrillation patients in 2011: a nationwide studyBMJ Open201335e002758
   PubMed Web of Science ®Google Scholar
• HylekEMEvans-MolinaCSheaCMajor hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillationCirculation2007115212689269617515465
   PubMed Web of Science ®Google Scholar
• GarciaDALopesRDHylekEMNew-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugsThromb Haemost201010461099110520886196
   PubMed Web of Science ®Google Scholar
• AnsellJHirshJHylekEAmerican College of Chest PhysiciansPharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th Edition)Chest20081336 Suppl160S198S18574265
   PubMed Web of Science ®Google Scholar
• SconceEAKhanTIWynneHAThe impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimenBlood200510672329233315947090
   PubMed Web of Science ®Google Scholar
• ReynoldsMWFahrbachKHauchOWarfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysisChest200412661938194515596696
   PubMed Web of Science ®Google Scholar
• MearnsESKohnCGSongJSMeta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patientsThromb Res2014134231031924935672
   PubMed Web of Science ®Google Scholar
• OakeNFergussonDAForsterAJFrequency of adverse events in patients with poor anticoagulation: a meta-analysisCMAJ2007176111589159417515585
   PubMed Web of Science ®Google Scholar
• FuruKWettermarkBAndersenMThe Nordic countries as a cohort for pharmacoepidemiological researchBasic Clin Pharmacol Toxicol20101062869419961477
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics MethodologyGuidelines for ATC Classification and DDD Assignment, 2013OsloWHO Collaborating Centre for Drug Statistics Methodology2014
   Google Scholar
• Finnish Medicines Agency and Social Insurance InstitutionFinnish Statistic of MedicineHelsinkiFinnish Medicines Agency and Social Insurance Institution2013
   Google Scholar
• SundRQuality of the Finnish Hospital Discharge Register: a systematic reviewScand J Public Health201240650551522899561
   PubMed Web of Science ®Google Scholar
• PottegårdAHallasJAssigning exposure duration to single prescriptions by use of the waiting time distributionPharmacoepidemiol Drug Saf201122880380923703741
   PubMed Web of Science ®Google Scholar
• KuijerPMHuttenBAPrinsMHPrediction of the risk of bleeding during anticoagulant treatment for venous thromboembolismArch Intern Med1999159545746010074953
   PubMed Web of Science ®Google Scholar
• GageBFvan WalravenCPearceLSelecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirinCirculation20041102287229215477396
   PubMed Web of Science ®Google Scholar
• QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care200543161130113916224307
   PubMed Web of Science ®Google Scholar
• BöttigerYLaineKAnderssonMLSFINX – a drug–drug interaction database designed for clinical decision support systemsEur J Clin Pharmacol200965662763319205683
   PubMed Web of Science ®Google Scholar
• HallinenTSoiniEJAsseburgCWarfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare dataBMJ Open201442e004071
   Web of Science ®Google Scholar
• HelinTMetsoTLassilaRINR testing results at the community clinics in the Hospital District of Helsinki and UusimaaFinn Med J20126715691574
   Google Scholar
• JonesMMcEwanPMorganCLEvaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British populationHeart200591447247715772203
   PubMed Web of Science ®Google Scholar
• HallasJDallMAndriesAUse of single and combined anti-thrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case–control studyBMJ2006333757172616984924
   PubMed Web of Science ®Google Scholar
• VitryAIRougheadEERamsayENMajor bleeding risk associated with warfarin and co-medications in the elderly populationPharmacoepidemiol Drug Saf201120101057106322039594
   PubMed Web of Science ®Google Scholar
• SuhDCChoiJCScheinJFactors associated with warfarin discontinuation, including bleeding patterns, in atrial fibrillation patientsCurr Med Res Opin201329776176723581534
   PubMed Web of Science ®Google Scholar
• LinkinsLO’DonnellMJulianJAIntracranial and fatal bleeding according to indication for long-term oral anticoagulant therapyJ Thromb Haemost20108102201220720723030
   PubMed Web of Science ®Google Scholar
• IlomäkiJHelin-SalmivaaraAHuupponenRAnalgesic use before and after oral anticoagulant initiation – a population-based study in FinlandEur J Clin Pharmacol201571672373225911438
   PubMed Web of Science ®Google Scholar
• ArnasonTWellsPSvan WalravenCAccuracy of coding for possible warfarin complications in hospital discharge abstractsThromb Res2006118225326216081144
   PubMed Web of Science ®Google Scholar
• ForslundTWettermarkBWändellPRisk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care systemInt J Cardiol2013170220821424239153
   PubMed Web of Science ®Google Scholar
• RikalaMHauta-AhoMHelin-SalmivaaraACo-prescribing of potentially interacting drugs during warfarin therapy – a population-based register studyBasic Clin Pharmacol Toxicol2015117212613225537751
   PubMed Web of Science ®Google Scholar